Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phoebe Ivain

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
JAMA Network Open|May 8, 2023
Whole-Body Hypothermia, Cerebral Magnetic Resonance Biomarkers, and Outcomes in Neonates With Moderate or Severe Hypoxic-Ischemic Encephalopathy Born at Tertiary Care Centers vs Other Facilities: A Nested Study Within a Randomized Clinical TrialSudhin Thayyil, Paolo Montaldo, Vaisakh Krishnan, et al.
Scientific Reports|August 6, 2020
Transcriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathyPaolo Montaldo, Aubrey Cunnington, Vania Oliveira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
The Lancet. Global Health|August 6, 2021
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and BangladeshSudhin Thayyil, Stuti Pant, Paolo Montaldo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
JAMA Network Open|May 8, 2023
Whole-Body Hypothermia, Cerebral Magnetic Resonance Biomarkers, and Outcomes in Neonates With Moderate or Severe Hypoxic-Ischemic Encephalopathy Born at Tertiary Care Centers vs Other Facilities: A Nested Study Within a Randomized Clinical TrialSudhin Thayyil, Paolo Montaldo, Vaisakh Krishnan, et al.
Scientific Reports|August 6, 2020
Transcriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathyPaolo Montaldo, Aubrey Cunnington, Vania Oliveira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
The Lancet. Global Health|August 6, 2021
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and BangladeshSudhin Thayyil, Stuti Pant, Paolo Montaldo, et al.
Pageof 2